Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Maria Ungericht, Valeria Groaz, Moritz Messner, Thomas Schuetz, Luca Brunelli, Marc-Michael Zaruba, Daniela Lener, Eva Stocker, Axel Bauer, Alexander Stephan Kroiss, Agnes Mayr, Christoph Röcken & Gerhard Poelzl. (2023) Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis. Amyloid 0:0, pages 1-10.
Read now
Read now
James C. Ross, David F. Hutt, Maria Burniston, Simona F. Grigore, Marianna Fontana, Joanne Page, Philip N. Hawkins, Janet A. Gilbertson, Dorota Rowczenio & Julian D. Gillmore. (2022) The role of serial 99mTc-DPD scintigraphy in monitoring cardiac transthyretin amyloidosis. Amyloid 29:1, pages 38-49.
Read now
Read now
Shin Yanagisawa, Yusuke Takahashi, Jun Sasaki, Ken Takasone, Koji Yoshie, Jun Koyama, Nagaaki Katoh, Masahide Yazaki, Koichiro Kuwahara, Yasunari Fujinaga & Yoshiki Sekijima. (2021) Absolute quantitative analysis of cardiac amyloidosis using SPECT/CT with 99mTc-pyrophosphate. Amyloid 28:3, pages 213-214.
Read now
Read now
Articles from other publishers (34)
Satoru Watanabe, Kenichi Nakajima, Fumihito Toshima, Hiroshi Wakabayashi, Shohei Yoshida, Hiroto Yoneyama, Junji Komatsu, Takahiro Konishi & Seigo Kinuya. (2023) Transthyretin amyloid cardiomyopathy disease burden quantified using 99mTc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours. Journal of Nuclear Cardiology 30:6, pages 2721-2735.
Crossref
Crossref
Francisco Sebastián Palacid, Noelia Álvarez Mena, Rosanna del Carmen Zambrano Infantino, María García Aragón, Mercedes Alonso Rodríguez, Berta Pérez López, Claudia Gamazo Laherrán, María Jesús González Soto & Ricardo Ruano Pérez. (2023) Absolute quantification of myocardial uptake of 99mTc-DPD in patients with cardiac amyloidosis due to transthyretin deposits (ATTR). Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 42:5, pages 302-309.
Crossref
Crossref
F. Sebastián Palacid, N. Álvarez Mena, R.C. Zambrano Infantino, M. García Aragón, M. Alonso Rodríguez, B. Pérez López, C. Gamazo Laherrán, M.J. González Soto & R. Ruano Pérez. (2023) Cuantificación absoluta de la captación miocárdica de 99mTc-DPD en pacientes con amiloidosis cardiaca por depósitos de transtiretina (ATTR). Revista Española de Medicina Nuclear e Imagen Molecular 42:5, pages 302-309.
Crossref
Crossref
Claudia Meier & Ali Yilmaz. (2023) Diagnostik der kardialen AmyloidoseDiagnostics of cardiac amyloidosis. Die Innere Medizin 64:9, pages 830-841.
Crossref
Crossref
Mirela Gherghe, Alexandra Maria Lazar, Maria-Carla Sterea, Paula Monica Spiridon, Natalia Motas, Laurentia Nicoleta Gales, Daniel Coriu, Sorina Nicoleta Badelita & Mario-Demian Mutuleanu. (2023) Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis—A New Dimension of Molecular Imaging. Journal of Cardiovascular Development and Disease 10:6, pages 242.
Crossref
Crossref
María del Carmen Mallón Araujo, Estephany Abou Jokh Casas, Charigan Abou Jokh Casas, Santiago Aguade Bruix, Álvaro Ruibal Morell & Virginia Pubul Núñez. (2023) Description of a different quantification method for amyloid burden (DPDload) and validation of SPECT/CT in cardiac amyloidosis. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 42:3, pages 171-177.
Crossref
Crossref
M.C. Mallón Araujo, E.A. Jokh Casas, C.A. Jokh Casas, S. Aguadé Bruix, A. Ruibal Morell & V. Pubul Núñez. (2023) Descripción de un método de cuantificación diferente para la carga de amiloide (DPDload) y validación de SPECT/TC en amiloidosis cardíaca. Revista Española de Medicina Nuclear e Imagen Molecular 42:3, pages 171-177.
Crossref
Crossref
Yiu Ming Khor, Sarah A. M. Cuddy, Vasvi Singh, Rodney H. Falk, Marcelo F. Di Carli & Sharmila Dorbala. (2023)
99m
Tc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis
. Radiology 306:2.
Crossref
Crossref
Jessica M. Duran & Salvador Borges-Neto. (2022) Bone scintigraphy imaging and transthyretin-related (ATTR) cardiac amyloidosis: New tricks from an old tool?. Journal of Nuclear Cardiology 30:1, pages 368-370.
Crossref
Crossref
Dominik C. Benz, Sharmila Dorbala & Aju P. Pazhenkottil. (2022) Quantifying the burden of cardiac amyloid: The future is about numbers!. Journal of Nuclear Cardiology 30:1, pages 112-115.
Crossref
Crossref
Tim Wollenweber, Elisabeth Kretschmer-Chott, Raphael Wurm, Sazan Rasul, Oana Kulterer, Rene Rettl, Franz Duca, Diana Bonderman, Kurt-Wolfram Sühs, Marcus Hacker & Tatjana Traub-Weidinger. (2022) Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?. Journal of Nuclear Cardiology 30:1, pages 357-367.
Crossref
Crossref
Lukas Kessler, Pedro Fragoso Costa, David Kersting, Walter Jentzen, Manuel Weber, Peter Lüdike, Alexander Carpinteiro, Sara Oubari, Tim Hagenacker, Andreas Thimm, Tienush Rassaf, Ken Herrmann, Maria Papathanasiou & Christoph Rischpler. (2022) Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis. Journal of Nuclear Cardiology 30:1, pages 101-111.
Crossref
Crossref
Sungwoo Bae, Joonhyung Gil, Jin Chul Paeng, Eun-Ah Park, Seung-Pyo Lee, Hongyoon Choi, Keon Wook Kang, Gi Jeong Cheon & Dong Soo Lee. (2022) Reliability and feasibility of visual grading systems and quantitative indexes on [99mTc]Tc-DPD imaging for cardiac amyloidosis. Scientific Reports 12:1.
Crossref
Crossref
Jean Michel Saad, Ahmed Ibrahim Ahmed, Yushui Han, Subha Saeed, Payam Pournazari & Mouaz H. Al-Mallah. (2021) 99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions. Heart Failure Reviews 27:5, pages 1493-1503.
Crossref
Crossref
Mehmet Harapoz, Scott Evans, Paul Geenty, Fiona Kwok, Graeme Stewart, Mark S. Taylor, David Farlow & Liza Thomas. (2022) Correlation of Quantitative 99mTc DPD Scintigraphy With Echocardiographic Alterations in Left Atrial Parameters in Transthyretin Amyloidosis. Heart, Lung and Circulation 31:6, pages 804-814.
Crossref
Crossref
Fabio Minutoli, Massimo Russo, Gianluca Di Bella, Riccardo Laudicella, Alessandro Spataro, Antonio Vento, Alessio Comis, Luca Gentile, Anna Mazzeo, Giuseppe Vita & Sergio Baldari. (2022) Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging. European Radiology 32:5, pages 3035-3044.
Crossref
Crossref
María del Carmen Mallón Araujo, Estephany Abou Jokh Casas, Charigan Abou Jokh Casas, Pablo Aguiar Fernández, María Amparo Martínez Monzonís, Bernardo Sopeña Pérez-Argüelles & Virginia Pubul Núñez. (2022) Enhanced quantitative method for the diagnosis of grade 1 cardiac amyloidosis in 99mTc-DPD scintigraphy. Scientific Reports 12:1.
Crossref
Crossref
Federico Caobelli & Cristina E. Popescu. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging
171
178
.
Chao Ren, Jingyun Ren, Zhuang Tian, Yanrong Du, Zhixin Hao, Zongyao Zhang, Wei Fang, Fang Li, Shuyang Zhang, Bailing Hsu & Li Huo. (2021) Assessment of cardiac amyloidosis with 99mTc-pyrophosphate (PYP) quantitative SPECT. EJNMMI Physics 8:1.
Crossref
Crossref
Simona Ben-Haim, A. Chicheportiche, E. Goshen, M. Arad, M. Smekhov, L. J. Menezes, P. M. Elliott, E. O’Mahoney, E. Stern, Bella Yuzefovich & J. B. Bomanji. (2021) Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis. EJNMMI Research 11:1.
Crossref
Crossref
Mehmet Harapoz, Scott Evans, Paul Geenty, Fiona Kwok, Graeme Stewart, Mark S. Taylor, David Farlow & Liza Thomas. (2021) Correlation Between Quantitative Uptake of 99mTC-DPD and Echocardiographic Parameters in Cardiac ATTR: A Novel Follow-Up Strategy. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Gary R. Small, Anthony Poulin, Anahita Tavoosi, Toby D. Small, Andrew M. Crean & Benjamin J. W. Chow. (2021) Cardiac Computed Tomography for Amyloidosis. Current Cardiovascular Imaging Reports 14:10.
Crossref
Crossref
Viktor Löfbacka, Jan Axelsson, Björn Pilebro, Ole B. Suhr, Per Lindqvist & Torbjörn Sundström. (2020) Cardiac transthyretin amyloidosis 99mTc-DPD SPECT correlates with strain echocardiography and biomarkers. European Journal of Nuclear Medicine and Molecular Imaging 48:6, pages 1822-1832.
Crossref
Crossref
Sharmila Dorbala, Mi-Ae Park, Sarah Cuddy, Vasvi Singh, Kyle Sullivan, Sirwoo Kim, Rodney H. Falk, Viviany R. Taqueti, Hicham Skali, Ron Blankstein, Camden Bay, Marie F. Kijewski & Marcelo F. Di Carli. (2021)
Absolute Quantitation of Cardiac
99m
Tc-Pyrophosphate Using Cadmium-Zinc-Telluride–Based SPECT/CT
. Journal of Nuclear Medicine 62:5, pages 716-722.
Crossref
Crossref
A. Yilmaz, J. Bauersachs, F. Bengel, R. Büchel, I. Kindermann, K. Klingel, F. Knebel, B. Meder, C. Morbach, E. Nagel, E. Schulze-Bahr, F. aus dem Siepen & N. Frey. (2021) Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK). Clinical Research in Cardiology 110:4, pages 479-506.
Crossref
Crossref
Gary R. Small & Terrence D. Ruddy. (2019) Straightening out the wrinkles in technetium-99m-labeled bone scintigraphy tracer assessment of cardiac amyloidosis. Journal of Nuclear Cardiology 28:1, pages 100-103.
Crossref
Crossref
Marianna Fontana, Ana Martinez-Naharro, Liza Chacko, Dorota Rowczenio, Janet A. Gilbertson, Carol J. Whelan, Svetla Strehina, Thirusha Lane, James Moon, David F. Hutt, Peter Kellman, Aviva Petrie, Philip N. Hawkins & Julian D. Gillmore. (2021) Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression. JACC: Cardiovascular Imaging 14:1, pages 189-199.
Crossref
Crossref
Tim Wollenweber, Rene Rettl, Elisabeth Kretschmer-Chott, Sazan Rasul, Oana Kulterer, Eva Rainer, Markus Raidl, Michael P. Schaffarich, Sabrina Matschitsch, Michael Stadler, Tatjana Traub-Weidinger, Dietrich Beiztke, Christian Loewe, Franz Duca, Julia Mascherbauer, Diana Bonderman & Marcus Hacker. (2020) In Vivo Quantification of Myocardial Amyloid Deposits in Patients with Suspected Transthyretin-Related Amyloidosis (ATTR). Journal of Clinical Medicine 9:11, pages 3446.
Crossref
Crossref
Stuart C. Ramsay & Claire Cuscaden. (2019) The current status of quantitative SPECT/CT in the assessment of transthyretin cardiac amyloidosis. Journal of Nuclear Cardiology 27:5, pages 1464-1468.
Crossref
Crossref
Federico Caobelli, Martin Braun, Philip Haaf, Damian Wild & Michael J. Zellweger. (2019) Quantitative 99mTc-DPD SPECT/CT in patients with suspected ATTR cardiac amyloidosis: Feasibility and correlation with visual scores. Journal of Nuclear Cardiology 27:5, pages 1456-1463.
Crossref
Crossref
Sharmila Dorbala, Marie Foley Kijewski & Mi-Ae Park. (2020) Quantitative Bone-Avid Tracer SPECT/CT for Cardiac Amyloidosis: A Crucial Step Forward. JACC: Cardiovascular Imaging 13:6, pages 1364-1367.
Crossref
Crossref
Erik B. Schelbert, Javed Butler & Javier Diez. (2019) Why Clinicians Should Care About the Cardiac Interstitium. JACC: Cardiovascular Imaging 12:11, pages 2305-2318.
Crossref
Crossref
Antonis S. Manolis, Antonis A. Manolis, Theodora A. Manolis & Helen Melita. (2019) Cardiac amyloidosis: An underdiagnosed/underappreciated disease. European Journal of Internal Medicine 67, pages 1-13.
Crossref
Crossref
A. Yilmaz, J. Bauersachs, I. Kindermann, K. Klingel, F. Knebel, B. Meder, C. Morbach, E. Nagel, E. Schulze-Bahr, F. aus dem Siepen & N. Frey. (2019) Diagnostik und Therapie der kardialen AmyloidoseDiagnostics and treatment of cardiac amyloidosis. Der Kardiologe 13:5, pages 264-291.
Crossref
Crossref